College of Pharmacy, Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul 120-750, Republic of Korea.
College of Pharmacy, CHA University, Pocheon 487-010, Republic of Korea.
Bioorg Chem. 2019 Mar;84:347-354. doi: 10.1016/j.bioorg.2018.11.054. Epub 2018 Nov 30.
Human DNA topoisomerases (topos) have been recognized as a good target molecule for the development of anticancer drugs because they play an important role in solving DNA topological problems caused by DNA strand separation during replication and transcription. In this study, we designed and synthesized 11 novel chromone backbone compounds possessing epoxy and halohydrin substituents with chirality. In the topos inhibition test, compounds 2, 9, 10, and 11 showed comparable topo I inhibitory activity at concentration of 100 μM compared to camptothecin, and all of the synthesized compounds showed moderate topo IIα inhibitory activity. Among them, compounds 9, 10 and 11 were more potent than the others in both topo I and IIα inhibitory activity. Compound 11 showed the most potent cell antiproliferative activity against all tested cancer cell lines with particularly strong inhibition (an IC of 0.04 µM) of K562 myelogenous leukemia cancer cell proliferation. In the brief structure-activity relationship analysis, there was no clear correlation between stereochemistry and topos inhibitory and cytotoxic activity. 5(R),7(S)-bisepoxy-substituted compound 11 was the most potent DNA cross-linker and induced G2/M arrest in a cell cycle assay in a dose- and time-dependent manner. After the treatment time period induced apoptosis in K562 cells without increasing G2/M-phase cells. Overall, compound 11 showed good consistent inhibitory biological activity related to cancer cell proliferation.
人类 DNA 拓扑异构酶(topos)已被认为是开发抗癌药物的良好靶标分子,因为它们在解决复制和转录过程中 DNA 链分离引起的 DNA 拓扑问题方面发挥着重要作用。在这项研究中,我们设计并合成了 11 种具有手性的新型色酮骨架化合物,这些化合物带有环氧和卤代醇取代基。在拓扑异构酶抑制试验中,与喜树碱相比,化合物 2、9、10 和 11 在 100µM 浓度下表现出相当的拓扑异构酶 I 抑制活性,所有合成的化合物均表现出中等的拓扑异构酶 IIα 抑制活性。其中,化合物 9、10 和 11 在拓扑异构酶 I 和 IIα 抑制活性方面均比其他化合物更为有效。化合物 11 对所有测试的癌细胞系均表现出最强的细胞增殖抑制活性,对 K562 髓性白血病癌细胞的抑制作用尤为强烈(IC 值为 0.04µM)。在简要的构效关系分析中,立体化学与拓扑异构酶抑制和细胞毒性活性之间没有明显的相关性。5(R),7(S)-双环氧取代的化合物 11 是最强的 DNA 交联剂,能够以剂量和时间依赖的方式诱导细胞周期分析中的 G2/M 期阻滞。在治疗时间段后,K562 细胞凋亡,而 G2/M 期细胞没有增加。总体而言,化合物 11 表现出与癌细胞增殖相关的良好一致的抑制生物活性。